Clinical Trials for Tempest Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Tempest Therapeutics

Clinical Trials (2)

NCT06680258
A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy
PHASE3Not yet recruiting
740 participants
Started: Dec 31, 2025 · Completed: Jul 31, 2030
1 condition2 sponsors0 locations
NCT04524871
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
PHASE1/PHASE2Recruiting
518 participants
Started: Nov 1, 2020 · Completed: Dec 31, 2026
1 condition5 sponsors33 locations